SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

AUROBINDO PHARMA

BSE: 524804 01 Jun 2025
Healthcare
₹ 1171.95
Aurobindo Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

AUROBINDO PHARMA - Share Price & Details

Market Cap
₹67,254
High /Low
1,593 / 994.0
Stock P/E
19.3
Book Value
₹557.0
Dividend Yield
0.39
ROCE
14.3
ROE
₹11.2
Face Value
1.0
PEG Ratio
4.83
EVEBITDA
₹9.38
Debt
8,263
CMP / FCF
10,818
Debt to equity
₹0.25
NP Ann
3,484
High price all time
1,593
Piotroski score
₹5.0
Graham Number
864.0
No. Eq. Shares
58.6
Net CF
₹2,169
Net profit
3,484
Price to book value
2.06
Interest Coverage
₹12.1
Low price all time
10.1
Industry PE
33.5
Reserves
₹32,595
Free Cash Flow
₹1,408

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and ServicNANANANA4.6330.9
Triochem Products Ltd.,NANANANA0
AUROBINDO PHARMA LTD.NANANANA67,25419.3
ABBOTT INDIA LTD.NANANANA6471745.8
Alkem Laboratories LimitedNANANANA6096028.2

Peer Comparison Chart


About AUROBINDO PHARMA

Aurobindo Pharma Ltd., with Security Code 524804, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

I-Sec downgrades Aurobindo Pharma to Add, target price Rs 1,330

(30 May 2025)
ICICI Securities has downgraded Aurobindo Pharma to 'Add' with a revised target price of Rs 1330, citing potential decline in gRevlimid...
Read more →

Aurobindo Pharma arm Curateq Biologics incorporates new wholly owned subsidiary in Netherlands

(30 May 2025)
Hyderabad: Aurobindo Pharma has announced that Curateq Biologics Private Limited, a wholly owned subsidiary of the Company, has incorporated...
Read more →

AUROBINDO PHARMA ARM INCORPORATES WOS IN NETHERLANDS

(29 May 2025)
The purpose of the incorporation of this wholly owned subsidiary is to expand the biopharma products business in Europe.
Read more →

Aurobindo Pharma Bull Vs Bear — The choice between underwhelming guidance and valuation comfort

(28 May 2025)
Shares of Aurobindo Pharma Ltd. declined over 2% on Wednesday, May 28, as analysts remain divided on the drugmaker's prospects after its...
Read more →

Aurobindo Pharma shares fall post Q4; Should you buy, sell or hold?

(28 May 2025)
Shares of Aurobindo Pharma Ltd fell 2.5 percent to Rs 1,161 in morning trade on May 28 after the company reported an 11 percent increase in...
Read more →

Aurobindo Pharma Q4 Results: Profit Stays Flat, Misses Estimates

(27 May 2025)
Aurobindo Pharma Ltd.'s fourth-quarter profit stayed almost flat in the fourth quarter of financial year 2024-25, thereby missing analysts'...
Read more →